Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

FFA's causes may include environmental triggers and genetic factors.

Macrophages are vital for skin healing, hair growth, salt balance, and cancer defense.

Some systemic treatments work for nail psoriasis but can have serious side effects.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Research on epidermal stem cells has advanced significantly, showing promise for improved clinical therapies.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Effective management of children's hair loss involves accurate diagnosis, various treatments, and supportive care.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

Hair loss in balding individuals is linked to changes in specific hair growth-related genes.

People with late-stage HIV-1 often experience a specific type of hair loss linked to multiple factors, including nutritional issues and immune responses.

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

Long-term fluticasone treatment does not harm the immune system in horses with heaves.

Prostaglandin F2α analogs show promise for treating certain types of hair loss but need more research for other skin conditions.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

New physical methods like electrical currents, ultrasound, and microneedles show promise for improving drug delivery through the skin.

FoxN1 gene is essential for proper thymus structure and preventing hair loss.

The BMP2 gene is more active in the early growth phase of Cashmere goat hair and may affect hair regeneration and textile production.

A specific DNA region is crucial for Foxn1 gene expression in thymus cells but not in hair follicles.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

People with vitiligo may have a higher rate of Helicobacter pylori infection, but the infection's severity doesn't affect how severe the vitiligo is.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Proteoglycans are important for hair growth, and a specific treatment can help reduce hair loss.